ASR Vermogensbeheer’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$50.9K Sell
561
-201,146
-100% -$18.4M ﹤0.01% 454
2026
Q1
$20.7M Buy
201,707
+3,839
+2% +$433K 0.24% 95
2025
Q4
$24.8M Sell
197,868
-1,772
-0.9% -$226K 0.29% 75
2025
Q3
$26.7M Sell
199,640
-906
-0.5% -$119K 0.32% 67
2025
Q2
$27.3M Buy
200,546
+1,419
+0.7% +$187K 0.35% 62
2025
Q1
$26.4M Buy
+199,127
New +$25.3M 0.39% 54

Other funds holding ABT

ASR Vermogensbeheer's ABT Position: Q2 2026 in Review

ASR Vermogensbeheer reduced its Abbott (ABT) stake by 100% in Q2 2026, selling an estimated $18.4M and leaving 561 shares worth $50.9K. The position accounts for ﹤0.01% of the portfolio, ranked #454.

ASR Vermogensbeheer first reported a position in ABT in Q1 2025 and has held it in 6 quarters since. The position peaked at $27.3M in Q2 2025. 2,956 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • ASR Vermogensbeheer held 561 shares of Abbott worth $50.9K as of Q2 2026.
  • ASR Vermogensbeheer sold 201,146 Abbott shares in Q2 2026, an estimated $18.4M.
  • Abbott made up ﹤0.01% of ASR Vermogensbeheer's portfolio in Q2 2026, its #454 holding.
  • ASR Vermogensbeheer first reported a position in Abbott in Q1 2025 and has held it in 6 quarters since.
  • ASR Vermogensbeheer's Abbott position peaked at $27.3M in Q2 2025.
  • 2,956 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on ASR Vermogensbeheer's 13F filing for Q2 2026, filed 20 Jul 2026.